Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Pappas Ventures Names Eric Linsley Managing Partner
News | 09. 28. 2009
Pappas Ventures today announced that Eric W. Linsley has been promoted to Managing Partner.
